These findings indicate that PTD-mediated delivery of GSTpi proteins can be an effective strategy for treating neuronal disease and further suggest that Tat-GSTpi proteins can be used to elucidate the roles and mechanisms within neuronal disease, including PD. This evidence concerns the gene TAT and Parkinson disease.